$RGBP I smell a buyout by Sybleu/Oncology Pharma? Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agenthttps://t.co/QhTiDIehdcpic.twitter.com/31iqReANdO
— EZpenny -my stock picks are my opinion- (@ezpenny_1) August 20, 2021